Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
High Risk
100%
Hypertensive Patients
100%
Amlodipine
100%
Valsartan
100%
Diabetes
83%
Confidence Interval
50%
Odds Ratio
50%
Type 1 Diabetes Mellitus (T1DM)
16%
Hypertension
16%
Cardiovascular Risk
16%
Health Problems
16%
Non-diabetic
16%
Fasting Plasma Glucose
16%
Adverse Events
16%
Angiotensin-converting Enzyme Inhibitor (ACEi)
16%
New-onset Type 2 Diabetes
16%
Angiotensin Receptor Blockers
16%
High Cardiovascular Risk
16%
Calcium Channel Antagonist
16%
Hydrochlorothiazide
16%
Strict Criteria
16%
Adverse Event Reporting
16%
Blood Glucose-lowering Drugs
16%
Add-on Medications
16%
Pharmacology, Toxicology and Pharmaceutical Science
Amlodipine
100%
Valsartan
100%
Non Insulin Dependent Diabetes Mellitus
100%
Diabetes Mellitus
40%
Adverse Event
40%
Cardiovascular Risk
20%
Dipeptidyl Carboxypeptidase Inhibitor
20%
Angiotensin Receptor Antagonist
20%
Calcium Channel Blocker
20%
Hydrochlorothiazide
20%
Amlodipine Plus Valsartan
20%
Cardiovascular Disease
20%
Diseases
20%